Expanded strategic and operational leadership positions Zenas for growth as obexelimab advances in late-stage clinical trials for multiple potential I&I indications WALTHAM, Mass., Dec. 04, 2023 (GLOBE NEWSWIRE) —  Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies, today announced the […]

A Media Snippet accompanying this announcement is available by clicking on this link. Most successful dinosaur exhibit of all-time More than 1.5 million visitors see Barbara and Peter – a world-first male & female T. rex pairing Barbara is one of only three female T. rex specimens ever discovered Auckland Museum breaks new ground by […]